The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
China Medical System Holdings Limited (“CMS” or the “Group”, 867.HK/8A8.SG) is pleased to announce that its subsidiary, ...
Clinical Trials Arena on MSN
Regulators starting to keep pace with innovative medicine development
With AI drug discovery speeding up innovative medicine discovery, regulators are ensuring they can properly support biotechs.
BEIJING, September 02, 2026--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing ...
The University of Hong Kong (HKU) and Grand Pharmaceutical Group Limited (Grand Pharmaceutical) have officially signed a research collaboration agreement, marking a significant step toward integrating ...
Press release from Gustave Roussy-Thursday 19 November 2026.
A long-running debate over prescription drug costs has centered on whether drug manufacturers are better rewarded for truly innovative medicines or so-called "me-too" drugs that may offer only ...
Membership gives city a role in shaping international standards as it works towards independently assessing drugs and medical ...
TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEssentia Corporation (TWSE: 6446), a Taiwan-based biopharmaceutical company, is expanding its global presence through new drug approvals, clinical trials and ...
Drug Innovation Ventures at Emory, LLC (DRIVE) will provide drug development and commercialization solutions for traditional academic drug discovery. Drug Innovation Ventures at Emory, LLC (DRIVE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results